Medtronic won a key court decision in its long-running battle about patent issues with medtech competitor Teleflex Inc. Pennsylvania-based Teleflex filed a lawsuit in 2019 alleging Medtronic's ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
In Medtronic, Inc., Medtronic Vascular, Inc. v. Teleflex Innovations S.A.R.L., the case addresses whether the final written decisions in a consolidated inter partes appeal (“IPR”) correctly found that ...
According to GlobalData, GUIDELINER is one of 67 product lines sold in the US cardiac catheters market; these product lines are sold by 17 different manufacturers. The average selling price for ...
Medtronic is weighing its next steps after losing another round in a long-running patent dispute with med-tech competitor Teleflex Inc. Teleflex has maintained that Medtronic violated its patents in ...
The US Court of Appeals for the Federal Circuit affirmed the Patent Trial & Appeal Board, holding that the Board did not err in finding certain challenged claims nonobvious and not unpatentable based ...
Teleflex’s patent claims for its interventional cardiology devices are patentable, a panel of judges ruled on Monday in a pair of decisions that boost the specialist device maker over medtech giant ...
“The fact that a competitor copied the patentee’s invention, rather than one within the public domain, is probative of nonobviousness because it suggests the competitor saw value in the invention that ...
“Although the patents themselves are the most important and, indeed, most persuasive evidence of the patents’ intended purpose, we find it is appropriate to consider extrinsic evidence, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results